A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation

Journal of Cell Science

Volumn 119, Issue 7, 2006, Pages 1433-1441

  Tabu, Kouichi ^a   Ohnishi, Akiko ^b   Sunden, Yuji ^a,c   Suzuki, Tadaki ^a   Tsuda, Masumi ^a   Tanaka, Shinya ^a   Sakai, Toshiyuki ^d   Nagashima, Kazuo ^a   Sawa, Hirofumi ^a,e  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

bHLH; Glioblastoma; OLIG2; p27; Transcription

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LUCIFERASE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; SMALL INTERFERING RNA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSACTIVATION; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA, COMPLEMENTARY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, REPORTER; GLIOMA; HUMANS; IMMUNOBLOTTING; LUCIFERASES; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEINS;

EID: 33646817730     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02854     Document Type: Article

References (50)

1. Aguirre-Cruz, L., Mokhtari, K., Hoang-Xuan, K., Marie, Y., Criniere, E., Taillibert, S., Lopes, M., Delattre, J. Y. and Sanson, M. (2004). Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors. J. Neurooncol. 67, 265-271.
2. Atchley, W. R. and Fitch, W. M. (1997). A natural classification of the basic helix-loop-helix class of transcription factors. Proc. Natl. Acad. Sci. USA 94, 5172-5176.
3. Baldassarre, G., Belletti, B., Nicoloso, M. S., Schiappacassi, M., Vecchione, A., Spessotto, P., Morrione, A., Canzonieri, V. and Colombatti, A. (2005). p27(Kipl)-stathmin interaction influence-sarcoma cell migration and invasion. Cancer Cell 7, 5 1-63.
4. Besson, A., Gurian-West, M., Schmidt, A., Hall, A. and Roberts, J. M. (2004). p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18, 962-876.
5. Cheney, I. W., Johnson, D. E., Vaillancourt, M. T., Avanzini, J., Morimoto, A., Demers, G. W., Wills.- K. N., Shabram, P. W., Bolen, J. B., Tavtigian, S. V. et al. (1998). Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res. 58, 2331-2334.
6. Cheney, I. W., Neuteboom, S. T., Vaillancourt, M. T., Ramachandra, M. and Bookstein, R. (1999). Adenovirus-mediated gene transfer of MMAC1/ PTEN to glioblastorna cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res. 59, 2318-2323.
7. Chew, L. J., King, W. C., Kennedy, A. and Gallo, V. (2005). Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells. Glia 52, 127-143.
8. Chodosb, L. A., Baldwin, A. S., Carthew, R. W. and Sharp, P. A. (1988). Human CCAAT-binding proteins have heterologous; subunits. Cell 53, 11,24.
9. Dingl, Q., Grammer, J. R., Nelson, M. A., Guan, J. L., Stewart, J. E., Jr and Gladson, C. L. (2005). p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. J. Biol. Chem. 280, 6802-6815.
10. Dorn, A., Bollekens, J., Staub, A., Benoist, C. and Mathis, D. (1987). A multiplicity of CCAAT box-binding proteins. Cell 50, 863-872.
11. Durand, B. and Raff, M. (2000). A cell-intrinsic rimer that operates during oligodendrocyte development. BioEssays 22, 64-71.
12. Durand, B., Gao, F. B. and Raff, M. (1997). Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16, 306-317.
13. Forget, M. A., Desrosiers, R. R., Del, M., Moumdjian, R., Shedid, D., Berthelet, F. and Beliveau, R. (2002). The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin. Exp. Metastasis 19, 9-15.
14. Furnari, F. B., Lin, H., Huang, H. S. and Cavenee, W. K. (1997). Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA 94, 12479-12484.
15. Fuse, T., Tanikawa, M., Nakanishi, M., Ikeda, K., Tada, T., Inagaki, H., Asai, K., Kato, T. and Yamada, K. (2000). p27Kip1 expression by contact inhibition as a prognostic index of human glioma. J. Neurochem, 74, 1393-1399.
16. Hooft van Huijsduijnen, R. A., Bollekens, J., Dorn, A., Benoist, C. and Mathis, D. (1987). Properties of a CCAAT box-binding protein. Nucleic Acids Res. 15, 7265-7282.
17. Inoue, T., Kamiyama, J. and Sakai, T. (1999). Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1) gene promoter that lacks vitamin D response elements. J. Biol. Chem. 274, 32309-32317.
18. Ishida, N., Hara, T., Kamura, T., Yoshida, M., Nakayama, K. and Nakayama, K. I. (2002). Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277, 14355-14358.
19. Komata, T., Kanzawa, T., Takeuchi, H., Germano, I. M., Schreiber, M., Kondo, Y. and Kondo, S. (2003). Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAFI/CIP1) and p27(KIP1)) on malignant glioma cells. Br. J. Cancer 88, 1277-1280.
20. Korshunov, A. and Golanov, A. (2001). The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas. Arch. Pathol. Lab. Med. 125, 892-898.
21. Korshunov, A., Golanov, A. and Sycheva, R. (2002). Immunohistochemical markers for prognosis of oligodendroglial neoplasms. J. Neurooncol. 58, 237-253.
22. Ledent, V. and Vervoort, M. (2001). The basic helix-loop-helix protein family: comparative genomics and phylogenetic analysis. Genome Res. 11, 754-770.
23. Ledent, V., Paquet, O. and Vervoort, M. (2002). Phylogenetic analysis of the human basic helix-loop-helix proteins. Genome Biol. 3, R30.1-R30.8.
24. Levine, E. M., Close, J., Fero, M., Ostrovsky, A. and Reh, T. A. (2000). p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299-314.
25. Ligon, K. L., Alberta, J. A., Kho, A. T., Weiss, J., Kwaan, M. R., Nutt, C. L., Louis, D. N., Stiles, C. D. and Rowitch, D. H. (2004). The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J. Neuropathol. Exp. Neurol. 63, 499-509.
26. Lu, Q. R., Park, J. K., Noll, E., Chan, J. A., Alberta, J., Yuk, D., Alzamora, M. G., Louis, D. N., Stiles, C. D., Rowitch, D. H. et al. (2001). Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc. Natl. Acad. Sci. USA 98, 10851-10856.
27. Lu, Q. R., Yuk, D., Alberta, J. A., Zhu, Z., Pawlitzky, I., Chan, J., McMahon, A. P., Stiles, C. D. and Rowitch, D. H. (2000). Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25, 317-329.
28. Mamillapalli, R., Gavrilova, N., Mihaylova, V. T., Tsvetkov, L. M., Wu, H., Zhang, H. and Sun, H. (2001). PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol. 11, 263-267.
29. Marie, Y., Sanson, M., Mokhtari, K., Leuraud, P., Kujas, M., Delattre, J. Y., Poirier, J., Zalc, B. and Hoang-Xuan, K. (2001). OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 358, 298-300.
30. McAllister, S. S., Becker-Hapak, M., Pintucci, G., Pagano, M. and Dowdy, S. F. (2003). Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mal. Cell. Biol. 23, 216-228.
31. Minami, S., Ohtani-Fujita, N., Igata, E., Tamaki, T. and Sakai, T. (1997). Molecular cloning and characterization of the human p27Kip1 gene promoter. FEBS Lett. 411, 1-6.
32. Mokhtari, K., Paris, S., Aguirre-Cruz, L., Privat, N., Criniere, E., Marie, Y., Hanw, J. J., Kujas, M., Rowitch, D., Hoang-Xuan, K. et al. (2005). Olig2 expression, GEAP, p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol. Appl. Neurobiol. 31, 62-69.
33. Morimoto, A. M., Berson, A. E., Fujii, G. H., Teng, D. H., Tavtigian, S. V., Bookstein, R., Steck, P. A. and Bolen, J. B.,(1999). Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase. Oncogene 18, 1261-1266.
34. Nakatsuji, Y. and Miller, R. H. (2001). Control of oligodendrocyte precursor proliferation mediated by density-dependent cell cycle protein expression. Dev. Neurosci. 23, 356-363.
35. Ohnishi, A., Sawa, H., Tsuda, M., Sawamura, Y., Itoh, T., Iwasaki, Y. and Nagashima, K. (2003). Expression of the ofigodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J. Neuropathol. Exp. Neurol. 62, 1052-1059.
36. Okada, Y., Sawa, H., Tanaka, S., Takada, A., Suzuki, S., Hasegawa, H., Umemura, T., Fujisawa, J., Tanaka, Y., Hall, W. W. et al. (2000). Transcriptional activation of JC virus by human T-lymphotropic virus type 1 Tax protein in human neuronal cell lines. J. Biol. Chem. 275, 17016-17023.
37. Piva, R., Cavalla, P., Bortolotto, S., Cordera, S., Richiardi, P, and Schiffer, D. (1997). p27/kip1 expression in human astrocytic gliomas. Neurosci. Lett. 234, 127-130.
38. Raff, M., Apperly, J., Kondo, T., Tokumoto, Y. and Tang, D. (2001). Timing cell-cycle exit and differentiation in oligodendrocyte development. Novartis Found. Symp. 237, 100-107.
39. Schiffer, D., Cavalla, F., Fiano, V., Ghimenti, C. and Piva, R. (2002). Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot. Neurosci. Lett. 328, 125-128.
40. Soos, T. J., Kiyokawa, H., Yan, J. S., Rubin, M. S., Giordano, A., DeBlasio, A., Bottega, S., Wong, B., Mendelsohn, J. and Koff, A. (1996). Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ 7, 135-146.
41. Takebayashi, H., Yoshida, S., Sugimori, M., Kosako, H., Korninami, R., Nakafuku, M. and Nabeshima, Y. (2000). Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech. Dev. 99, 143-148.
42. Tamiya, T., Mizumatsu, S., Ono, Y., Abe, T., Matsumoto, K., Furuta, T. and Ohmoto, T. (2001). High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Acta Neuropathol. (Berl.) 101, 334-340.
43. Tokumoto, Y. M., Apperly, J. A., Gao, F. B. and Raff, M. C. (2002). Posttranscriptional regulation of p18 and p27 Cdk inhibitor proteins and the timing of oligodendrocyte differentiation. Dev. Biol 245, 224-234.
44. Yokoo, H., Nobusawa, S., Takebayashl, H., Ikenaka, K., Isoda, K., Kamiya, M., Sasaki, A., Hirato, J. and Nakazato, Y. (2004). Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am. J. Pathol. 164, 1717-1725.
45. Zagzag, D., Blanco, C., Friedlander, D. R., Miller, D. C. and Newcomb, E. W. (2003). Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Hum. Pathol. 34, 48-53.
46. Zezula, J., Casaccia-Bonnefil, F., Ezhevsky, S. A., Osterhout, D. J., Levine, J. M., Dowdy, S. F., Chao, M. V. and Koff, A. (2001). p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep. 2,27-34.
47. Zhang, X., Wharton, W., Donovan, M., Coppola, D., Croxton, R., Cress, W. D. and Pledger, W. J. (2000). Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Mol. Biol. Cell 11, 2117-2130.
48. Zhang, Y. and Lin, S. C. (1997). Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. Biochim. Biophys. Acta 1353, 307-317.
49. Zhou, Q., Choi, G. and Anderson, D. J. (2001). The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 31, 791-807.
50. Zhou, Q., Wang, S. and Anderson, D. J. (2000). Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25, 331-343.